Related Experiment Video
Updated: Jul 20, 2026

07:47
Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
Enzymatic activation of lysine 2,3-aminomutase from Porphyromonas gingivalis
Brian J Brazeau1, Steven J Gort, Holly J Jessen
1Biotechnology Development Center-Eddyville, Cargill Incorporated, 1 Cargill Drive, Eddyville, IA 52553, USA. brian_brazeau@cargill.com
Applied and Environmental Microbiology
|September 8, 2006
Abstract:
The development of lysine 2,3-aminomutase as a robust biocatalyst hinges on the development of an in vivo activation system to trigger catalysis. This is the first report to show that, in the absence of chemical reductants, lysine 2,3-aminomutase activity is dependent upon the presence of flavodoxin, ferredoxin, or flavodoxin-NADP(+) reductase.

